🇺🇸 FDA
Patent

US 12377112

Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

granted A61KA61K31/4045A61K31/661

Quick answer

US patent 12377112 (Methods of treating neurocognitive disorders, chronic pain and reducing inflammation) held by Compass Pathfinder Limited expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Pathfinder Limited
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4045, A61K31/661, A61K31/675, A61K9/0053